Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial (Q33406742)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial |
scientific article |
Statements
1 reference
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial (English)
1 reference
M Fanale
1 reference
S S Neelapu
1 reference
R Champlin
1 reference
M Wang
1 reference
N Fowler
1 reference
N Wagner-Bartak
1 reference
L Feng
1 reference
J Romaguera
1 reference
F Hagemeister
1 reference
Y Oki
1 reference
B Pro
1 reference
J Shah
1 reference
S Thomas
1 reference
A Younes
1 reference
L Zhang
1 reference
K J Newberry
1 reference
M Desai
1 reference
N Cheng
1 reference
M Badillo
1 reference
M Bejarano
1 reference
Y Chen
1 reference
K H Young
1 reference
L Kwak
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference